Century Therapeutics, Inc. (IPSC) Retained Earnings (Accumulated Deficit) USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Century Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2020 to 2024.
  • Century Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$684 M, a 24.3% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$684 M -$133 M -24.3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$656 M -$137 M -26.3% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$616 M -$129 M -26.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$584 M -$127 M -27.8% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$550 M -$125 M -29.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$519 M -$131 M -33.7% Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$487 M -$127 M -35.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$457 M -$123 M -36.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$426 M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$388 M -$95.8 M -32.8% Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$360 M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$334 M Jun 30, 2021 10-Q 2021-08-12
Q4 2020 -$292 M Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.